"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...
Administration of PhosLo (calcium acetate tablet) in excess of the appropriate daily dosage can cause severe hypercalcemia (See ADVERSE REACTIONS).
Patients with hypercalcemia.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 5/27/2009
Additional Phoslo Information
Phoslo - User Reviews
Phoslo User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.